Conestoga Capital Advisors, LLC Neogenomics Inc Transaction History

Conestoga Capital Advisors, LLC

  • $7.22 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 25, 2019
SELL
$19.12 - $26.24 $226,380 - $310,681
-11,840 Closed
0 $0
Q2 2019

Aug 02, 2019
SELL
$19.57 - $24.1 $130,336 - $160,506
-6,660 Reduced 36.0%
11,840 $260,000
Q1 2019

Apr 18, 2019
BUY
$12.14 - $20.46 $224,590 - $378,510
18,500 New
18,500 $379,000

Others Institutions Holding NEO

# of Institutions
295
Shares Held
125M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email